海正药业：关于调整限制性股票回购价格及回购注销部分激励对象已获授但尚未解除限售的限制性股票的公告

Core Viewpoint - The company announced an adjustment to the repurchase price of restricted stock and the cancellation of certain stock options due to changes in eligibility and performance criteria [1] Group 1: Stock Repurchase and Adjustment - The company plans to adjust the repurchase price of reserved restricted stock from 8.56 yuan per share to 8.35 yuan per share [1] - This adjustment follows the completion of the company's 2024 annual equity distribution [1] Group 2: Cancellation of Stock Options - The company intends to cancel a total of 87,000 shares of restricted stock held by seven individuals who no longer qualify for stock incentives and two individuals who did not meet personal performance assessment requirements [1] - This cancellation is in accordance with the company's 2021 restricted stock incentive plan and the authorization from the second extraordinary general meeting of shareholders in 2021 [1]